Back to COGT
UBS Group AG COGT Position History
Cogent Biosciences, Inc. • Healthcare
Quarters held
13
Latest value
$320K
Q3 2026
Peak value
$53.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $26.6M |
| Q4 2025 | $9.3M |
| Q4 2025 | $61K |
| Q1 2026 | $370K |
| Q1 2026 | $10.8M |
| Q1 2026 | $58K |
| Q2 2026 | $384K |
| Q2 2026 | $42.9M |
| Q2 2026 | $164K |
| Q3 2026 | $67K |
| Q3 2026 | $53.2M |
| Q3 2026 | $195K |
| Q3 2026 | $320K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $320K | 10.0K | — | — |
| Q3 2026 | $195K | 6.1K | — | — |
| Q3 2026 | $53.2M | 1.66M | — | — |
| Q3 2026 | $67K | 2.1K | — | — |
| Q2 2026 | $164K | 4.2K | — | — |
| Q2 2026 | $42.9M | 1.11M | — | — |
| Q2 2026 | $384K | 9.9K | — | — |
| Q1 2026 | $58K | 1.5K | — | — |
| Q1 2026 | $10.8M | 280.4K | — | — |
| Q1 2026 | $370K | 9.6K | — | — |
| Q4 2025 | $61K | 1.7K | — | — |
| Q4 2025 | $9.3M | 262.3K | — | — |
| Q3 2025 | $26.6M | 1.85M | — | — |
Other funds holding COGT
$868.7M
$808M
$756M
$706.8M